logo
Plus   Neg
Share
Email

Vanda Pharmaceutical Inc. (VNDA) Has Risen To A New High After Q3 Report

Vanda Pharmaceutical Inc. (VNDA) reported third quarter adjusted EPS of $0.20 after the bell Wednesday, compared to the loss of $0.03 in the prior year.

Vanda Pharmaceutical gapped up at the open Thursday and has continued to rise in early trade. Shares are now up 3.58 at $24.03. The stock has broken out past resistance and has set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Momentum

0 Articles
Follow RTT